RecallDepth
Class III Terminated

bupPROPion HCL Extended-Release Tablets, USP (XL) 300 mg, 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. NDC: 0378-2009-05

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
November 3, 2017
Posted
January 31, 2018
Recall Number
D-0230-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,414/500 count bottles
Firm Location
Morgantown, WV, United States

Reason for Recall

Failed Impurities/Degradation Specifications: Mylan Pharmaceuticals Inc. is conducting a voluntary recall due to related out of specification compound results obtained during routine stability testing.

Distribution

Product was distributed nationwide in the USA

Lot / Code Info

Lot # 3077281, EXP 06-2018

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class III Drug recalls